1678 related articles for article (PubMed ID: 28008784)
1. Therapeutic interventions for gut dysbiosis and related disorders in the elderly: antibiotics, probiotics or faecal microbiota transplantation?
Vemuri RC; Gundamaraju R; Shinde T; Eri R
Benef Microbes; 2017 Apr; 8(2):179-192. PubMed ID: 28008784
[TBL] [Abstract][Full Text] [Related]
2.
Mullish BH; Williams HR
Clin Med (Lond); 2018 Jun; 18(3):237-241. PubMed ID: 29858434
[TBL] [Abstract][Full Text] [Related]
3. Different Strategies Targeting Gut Microbiota for the Management of Several Disorders: A Sustainable Approach.
Chowdhury M; Raj Chaudhary N; Kaur P; Goyal A; Sahu SK
Infect Disord Drug Targets; 2024; 24(5):e160124225675. PubMed ID: 38317473
[TBL] [Abstract][Full Text] [Related]
4. Gut dysbacteriosis and intestinal disease: mechanism and treatment.
Meng X; Zhang G; Cao H; Yu D; Fang X; de Vos WM; Wu H
J Appl Microbiol; 2020 Oct; 129(4):787-805. PubMed ID: 32277534
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic advances in non-alcoholic fatty liver disease: A microbiota-centered view.
Chen HT; Huang HL; Li YQ; Xu HM; Zhou YJ
World J Gastroenterol; 2020 Apr; 26(16):1901-1911. PubMed ID: 32390701
[TBL] [Abstract][Full Text] [Related]
6. The effect of microbiome therapy on COVID-19-induced gut dysbiosis: A narrative and systematic review.
Yousef M; Rob M; Varghese S; Rao S; Zamir F; Paul P; Chaari A
Life Sci; 2024 Apr; 342():122535. PubMed ID: 38408636
[TBL] [Abstract][Full Text] [Related]
7. Antibiotic-associated Gut Dysbiosis.
Ramakrishna BS; Patankar R
J Assoc Physicians India; 2023 Nov; 71(11):62-68. PubMed ID: 38720499
[TBL] [Abstract][Full Text] [Related]
8. A Comprehensive Review on the Role of the Gut Microbiome in Human Neurological Disorders.
Sorboni SG; Moghaddam HS; Jafarzadeh-Esfehani R; Soleimanpour S
Clin Microbiol Rev; 2022 Jan; 35(1):e0033820. PubMed ID: 34985325
[TBL] [Abstract][Full Text] [Related]
9. Understanding the gut microbiota and sarcopenia: a systematic review.
Liu C; Cheung WH; Li J; Chow SK; Yu J; Wong SH; Ip M; Sung JJY; Wong RMY
J Cachexia Sarcopenia Muscle; 2021 Dec; 12(6):1393-1407. PubMed ID: 34523250
[TBL] [Abstract][Full Text] [Related]
10. Dysbiosis in Irritable Bowel Syndrome.
Abraham P; Pratap N
J Assoc Physicians India; 2023 Sep; 71(9):75-81. PubMed ID: 38700306
[TBL] [Abstract][Full Text] [Related]
11. Gut microbiome-targeted therapies for Alzheimer's disease.
Zhang T; Gao G; Kwok LY; Sun Z
Gut Microbes; 2023 Dec; 15(2):2271613. PubMed ID: 37934614
[TBL] [Abstract][Full Text] [Related]
12. Microbial-Based and Microbial-Targeted Therapies for Inflammatory Bowel Diseases.
Oka A; Sartor RB
Dig Dis Sci; 2020 Mar; 65(3):757-788. PubMed ID: 32006212
[TBL] [Abstract][Full Text] [Related]
13. Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes.
Huda MN; Kim M; Bennett BJ
Front Endocrinol (Lausanne); 2021; 12():632335. PubMed ID: 33897618
[TBL] [Abstract][Full Text] [Related]
14. Unveiling and harnessing the human gut microbiome in the rising burden of non-communicable diseases during urbanization.
Huang Z; Li Y; Park H; Ho M; Bhardwaj K; Sugimura N; Lee HW; Meng H; Ebert MP; Chao K; Burgermeister E; Bhatt AP; Shetty SA; Li K; Wen W; Zuo T
Gut Microbes; 2023; 15(1):2237645. PubMed ID: 37498052
[TBL] [Abstract][Full Text] [Related]
15. Modulating the gut microbiota by probiotics, prebiotics, postbiotics, and fecal microbiota transplantation: An emerging trend in cancer patient care.
Ciernikova S; Sevcikova A; Drgona L; Mego M
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188990. PubMed ID: 37742728
[TBL] [Abstract][Full Text] [Related]
16. From dysbiosis to defense: harnessing the gut microbiome in HIV/SIV therapy.
Brenchley JM; Serrano-Villar S
Microbiome; 2024 Jun; 12(1):113. PubMed ID: 38907315
[TBL] [Abstract][Full Text] [Related]
17. The role of the gut microbiota in tumor, immunity, and immunotherapy.
Xie Y; Liu F
Front Immunol; 2024; 15():1410928. PubMed ID: 38903520
[TBL] [Abstract][Full Text] [Related]
18. Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate.
Gallo A; Passaro G; Gasbarrini A; Landolfi R; Montalto M
World J Gastroenterol; 2016 Aug; 22(32):7186-202. PubMed ID: 27621567
[TBL] [Abstract][Full Text] [Related]
19. Application of Microbiome-Based Therapies in Chronic Respiratory Diseases.
Lee SH; Lee JH; Lee SW
J Microbiol; 2024 Mar; 62(3):201-216. PubMed ID: 38635003
[TBL] [Abstract][Full Text] [Related]
20. Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis.
Gut Microbes; ; . PubMed ID: 37979154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
